Turn Therapeutics Inc.
NGM: TTRXLive Quote
📈 ZcoreAI Score
Our AI model analyzes Turn Therapeutics Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get TTRX Z-Score →About Turn Therapeutics Inc.
Healthcare
Biotechnology
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
📊 Fundamental Analysis
Turn Therapeutics Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -141.7%, which indicates that capital utilization is currently under pressure.
At a current price of $3.35, TTRX currently trades near the bottom of its 52-week range (3%), indicating potential value or weakness (Range: $2.57 - $26.50).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Return on Equity
Weak
Key Financials
Market Cap
$99.79M
Trailing P/E
--
Forward P/E
-22.33
Beta (5Y)
--
52W High
$26.50
52W Low
$2.57
Avg Volume
28K
Day High
Day Low